Thomas F. Kirk Buys 7,400 Shares of Myomo, Inc. (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO - Get Free Report) Director Thomas F. Kirk acquired 7,400 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was purchased at an average cost of $5.00 per share, for a total transaction of $37,000.00. Following the completion of the acquisition, the director now directly owns 255,933 shares of the company's stock, valued at approximately $1,279,665. This trade represents a 2.98 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

Myomo Stock Down 2.4 %

Shares of MYO traded down $0.13 during mid-day trading on Tuesday, reaching $5.31. The company had a trading volume of 569,341 shares, compared to its average volume of 336,184. Myomo, Inc. has a 52-week low of $2.51 and a 52-week high of $7.17. The company has a market capitalization of $160.63 million, a price-to-earnings ratio of -23.09 and a beta of 1.68.

Analyst Ratings Changes

A number of research analysts have recently weighed in on MYO shares. HC Wainwright increased their price objective on Myomo from $7.50 to $9.50 and gave the company a "buy" rating in a report on Wednesday, March 12th. Alliance Global Partners reissued a "buy" rating on shares of Myomo in a report on Tuesday, March 11th. Ascendiant Capital Markets increased their price objective on Myomo from $9.00 to $11.00 and gave the company a "buy" rating in a report on Monday. Finally, Craig Hallum upped their target price on Myomo from $9.00 to $11.00 and gave the stock a "buy" rating in a research note on Tuesday, March 11th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Myomo currently has an average rating of "Buy" and a consensus price target of $9.75.

Remove Ads

Institutional Trading of Myomo

A number of hedge funds have recently modified their holdings of the stock. Barclays PLC purchased a new position in Myomo during the third quarter worth approximately $36,000. BNP Paribas Financial Markets purchased a new position in Myomo during the fourth quarter worth approximately $64,000. Jane Street Group LLC purchased a new position in Myomo during the third quarter worth approximately $65,000. Walleye Capital LLC purchased a new position in Myomo during the fourth quarter worth approximately $66,000. Finally, Squarepoint Ops LLC purchased a new position in Myomo during the fourth quarter worth approximately $74,000. Hedge funds and other institutional investors own 44.99% of the company's stock.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.